Literature DB >> 21498693

Anticancer effects of novel photodynamic therapy with glycoconjugated chlorin for gastric and colon cancer.

Mamoru Tanaka1, Hiromi Kataoka, Motoshi Mabuchi, Shiho Sakuma, Satoru Takahashi, Ryoto Tujii, Haruo Akashi, Hiromi Ohi, Shigenobu Yano, Akimichi Morita, Takashi Joh.   

Abstract

BACKGROUND/AIM: Photodynamic therapy (PDT) is an attractive, minimally invasive modality for cancer therapy that utilizes the interaction of light and photosensitizer. To improve the efficacy of PDT, development of cancer specificity of the photosensitizer is needed. Cancer cells consume more glucose than normal cells. In this study, the efficacy of PDT using a newly developed photosensitizer, glycoconjugated chlorin (H2TFPC-SGlc), was compared with Talaporfin, which is clinically used in Japan.
MATERIALS AND METHODS: Photosensitizers were administered to gastric and colon cancer cell lines, followed by irradiation of light, and the cell death-inducing effects were compared. Xenograft tumor mouse models were established and photosensitizer accumulation was assessed and antitumor effects analyzed.
RESULTS: In vitro, H(2)TFPC-SGlc was 30 times more cytotoxic to cancer cells than was Talaporfin. In vivo, H(2)TFPC-SGlc accumulation was higher in xenograft tumors and significantly suppressed tumor growth when compared with Talaporfin.
CONCLUSION: This novel glycoconjugated chlorin is potentially useful in PDT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21498693

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  19 in total

Review 1.  Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics.

Authors:  Sunaina Singh; Amit Aggarwal; N V S Dinesh K Bhupathiraju; Gianluca Arianna; Kirran Tiwari; Charles Michael Drain
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

Review 2.  New photodynamic therapy with next-generation photosensitizers.

Authors:  Hiromi Kataoka; Hirotada Nishie; Noriyuki Hayashi; Mamoru Tanaka; Akihiro Nomoto; Shigenobu Yano; Takashi Joh
Journal:  Ann Transl Med       Date:  2017-04

Review 3.  Fluorinated porphyrinoids as efficient platforms for new photonic materials, sensors, and therapeutics.

Authors:  N V S Dinesh K Bhupathiraju; Waqar Rizvi; James D Batteas; Charles Michael Drain
Journal:  Org Biomol Chem       Date:  2016-01-14       Impact factor: 3.876

4.  Comparison of a new nanoform of the photosensitizer chlorin e6, based on plant phospholipids, with its free form.

Authors:  Lyubov V Kostryukova; Vladimir N Prozorovskiy; Natalya V Medvedeva; Olga M Ipatova
Journal:  FEBS Open Bio       Date:  2018-01-02       Impact factor: 2.693

5.  Investigation of LED-based photodynamic therapy efficiency on breast cancer cells.

Authors:  Ali Furkan Kamanlı; Mustafa Zahid Yıldız; Ebru Özyol; Asuman Deveci Ozkan; Elif Sozen Kucukkara; Gamze Guney Eskiler
Journal:  Lasers Med Sci       Date:  2020-06-23       Impact factor: 3.161

6.  Enzymatic synthesis of lactosylated and sialylated derivatives of epothilone A.

Authors:  Prakash Parajuli; Ramesh Prasad Pandey; Rit Bahadur Gurung; Ju Yong Shin; Hye Jin Jung; Dae Hee Kim; Jae Kyung Sohng
Journal:  Glycoconj J       Date:  2016-02-06       Impact factor: 2.916

Review 7.  Photodynamic therapy in gastroenterology.

Authors:  N Shishkova; O Kuznetsova; T Berezov
Journal:  J Gastrointest Cancer       Date:  2013-09

8.  Fluorescence characteristics and lifetime images of photosensitizers of talaporfin sodium and sodium pheophorbide a in normal and cancer cells.

Authors:  Kamlesh Awasthi; Kazuhito Yamamoto; Kazunari Furuya; Takakazu Nakabayashi; Liming Li; Nobuhiro Ohta
Journal:  Sensors (Basel)       Date:  2015-05-18       Impact factor: 3.576

9.  A glucose carbonate apatite complex exhibits in vitro and in vivo anti-tumour effects.

Authors:  Hirofumi Yamamoto; Xin Wu; Hiroyuki Nakanishi; Yuki Yamamoto; Mamoru Uemura; Taishi Hata; Junichi Nishimura; Ichiro Takemasa; Tsunekazu Mizushima; Jun-Ichi Sasaki; Satoshi Imazato; Nariaki Matsuura; Yuichiro Doki; Masaki Mori
Journal:  Sci Rep       Date:  2015-01-13       Impact factor: 4.379

10.  Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells.

Authors:  Mamoru Tanaka; Hiromi Kataoka; Shigenobu Yano; Hiromi Ohi; Keisuke Kawamoto; Takashi Shibahara; Tsutomu Mizoshita; Yoshinori Mori; Satoshi Tanida; Takeshi Kamiya; Takashi Joh
Journal:  BMC Cancer       Date:  2013-05-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.